Yong Suk Jang
Chonbuk National University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Yong Suk Jang.
Vaccine | 2003
Jong Lye Bae; Jong Gul Lee; Tae-Jin Kang; Hyon Seok Jang; Yong Suk Jang; Moon Sik Yang
A report from that the presence of lactogenic immunity in pigs protected suckling piglets from porcine epidemic diarrhea virus (PEDV) infection suggested that inducing mucosal immune responses in lactating pigs is an effective way of protecting swine from PEDV infection. In this study, we developed transgenic tobacco plants that express the antigen protein corresponding to the neutralizing epitope of PEDV spike protein, and tested whether feeding the plants to pigs induced an effective immune response against PEDV infection. First, we confirmed the immunogenicity of the plant-derived antigen by using a plaque reduction neutralization assay with serum obtained after injecting mice with protein extracted from the transgenic plants. Feeding the transgenic plants to mice induced both systemic and mucosal immune responses against the antigen. The induced antibodies inhibited virus infection in the plaque reduction neutralization assay. These results suggest that feeding animals transgenic plants carrying antigen genes is an effective strategy to induce protective immune responses against PEDV infection.
FEBS Letters | 2015
Chung Hyeon Choe; In Sun Park; Jisang Park; Kang Yeol Yu; Hyon-Seok Jang; Ju Kim; Yong Suk Jang
Tmem173 was identified as a growth inhibitor associated with major histocompatibility complex (MHC) class II and a potential stimulator for IFN‐β, an innate immune inducer and a negative feedback controller for RANKL‐induced osteoclast differentiation of monocytic macrophage cells. In this study, we confirmed that transmembrane protein 173 (Tmem173) overexpression inhibited the expression of osteoclast‐specific genes, tartrate‐resistant acid phosphatase (TRAP), cathepsin K, and matrix metalloproteinase‐9 (MMP‐9), as well as bone resorption pit formation in RANKL‐treated RAW 264.7 cells. Activation of osteoclast‐specific transcription factors, c‐Fos and nuclear factor of activated T cells cytoplasmic‐1 (NFATc1), and RANKL‐induced activation of ERK were also down‐regulated by Tmem173 overexpression. Collectively, these results suggest that Tmem173 plays a regulatory role in RANKL–RANK‐mediated signaling in osteoclastogenesis.
Pharmaceutical Biology | 2017
Sun Hee Jang; Jisang Park; Sae Hae Kim; Kyung Min Choi; Eun Sil Ko; Jeong-Dan Cha; Young Ran Lee; Hyon-Seok Jang; Yong Suk Jang
Abstract Context: Red ginseng (heat-processed Panax ginseng) is a well-known alternative medicine with pharmacological antidiabetic activity. It exerts pharmacological effects through the transformation of saponin into metabolites by the intestinal microbiota. Given that intestinal conditions and intestinal microflora vary among individuals, the pharmacological effects of orally administered red ginseng likely may vary among individuals. Objective: To overcome this variation and produce homogeneously effective red ginseng, we evaluated the antidiabetic effects of probiotic-fermented red ginseng in a mouse model. Materials and methods: The antidiabetic efficacy of orally administered probiotic-fermented red ginseng was assessed in ICR mice after induction of diabetes using streptozotocin (170 mg/kg body weight). Samples were given orally for 8 weeks, and indicators involved in diabetic disorders such as body weight change, water intake, blood glucose, glucose tolerance and various biochemical parameters were determined. Results: Oral administration of probiotic-fermented red ginseng significantly decreased the level of blood glucose of about 62.5% in the fasting state and induced a significant increase in glucose tolerance of about 10.2% compared to the control diabetic mice. Additionally, various indicators of diabetes and biochemical data (e.g., blood glycosylated haemoglobin level, serum concentrations of insulin, and α-amylase activity) showed a significant improvement in the diabetic conditions of the mice treated with probiotic-fermented red ginseng in comparison with those of control diabetic mice. Discussion and conclusion: Our results demonstrate the antidiabetic effects of probiotic-fermented red ginseng in the streptozotocin-induced mouse diabetes model and suggest that probiotic-fermented red ginseng may be a uniformly effective red ginseng product.
Immune Network | 2017
Jisang Park; Chung Hyeon Choe; Ju Kim; Jing Shian Yang; Jin Hyun Kim; Hyon-Seok Jang; Yong Suk Jang
Major histocompatibility complex (MHC) class II molecules, which are recognized for their primary function of presenting an antigen to the T cell receptor, are involved in various signaling pathways in B cell activation. We identified heterogeneous nuclear ribonucleoprotein (hnRNP) A2B1 as an MHC class II molecule-associated protein involved in MHC class II-mediated signal transduction in lipopolysaccharide (LPS)-stimulated 38B9 B cells. Although the function of hnRNP A2B1 in the nucleus is primarily known, the level of hnRNP A2B1 in the cytoplasm was increased in LPS-stimulated 38B9 cells, while it was not detected in the cytoplasm of non-treated 38B9 cells. The silencing of hnRNP A2B1 expression using siRNA disturbed B cell maturation by regulation of mitogen-activated protein kinase signaling, NF-κB activation, and protein kinase B activation. These results suggest that hnRNP A2B1 is associated with MHC class II molecules and is involved in B cell activation signaling pathways in LPS-stimulated 38B9 cells.
Biochimica et Biophysica Acta | 2005
Hyon Seok Jang; Sung Ho Kook; Young Ok Son; Jong Ghee Kim; Young Mi Jeon; Yong Suk Jang; Ki Choon Choi; Ju Kim; Seong Kyu Han; Kyung Yeol Lee; Byung Keon Park; Nam Pyo Cho; Jeong Chae Lee
Toxicology Letters | 2005
Young Ok Son; Kyung Yeol Lee; Jeong Chae Lee; Hyon Seok Jang; Jong Ghee Kim; Young Mi Jeon; Yong Suk Jang
Protein Expression and Purification | 2007
Tae Geum Kim; Mi-Young Kim; Bang Geul Kim; Tae-Jin Kang; Young Sook Kim; Yong Suk Jang; Charles J. Arntzen; Moon Sik Yang
Fems Immunology and Medical Microbiology | 2006
Kyung Yeol Lee; Dong Heon Kim; Tae-Jin Kang; Ju Kim; Gook Hyun Chung; Han Sang Yoo; Charles J. Arntzen; Moon Sik Yang; Yong Suk Jang
Molecules and Cells | 2001
Sojin Jung; Young Kwan Chung; Sun Hwa Chang; Ju Kim; Hak Ryul Kim; Hyon Seok Jang; Jeong Chae Lee; Gook Hyun Chung; Yong Suk Jang
Molecules and Cells | 2000
Tai Hyoung Cho; Sun Hwa Chang; Yong Suk Jang